Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: Case-series

Croatian Medical Journal

Volumn 48, Issue 2, 2007, Pages 234-239

  Erdeve, Omer ^a,c   Uras, Nurdan ^b   Atasay, Begum ^a   Arsan, Saadet ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DORNASE ALFA;

ARTICLE; ATELECTASIS; BREATHING RATE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MUCUS GLAND; NEWBORN; OXYGEN CONSUMPTION; SINGLE DRUG DOSE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ATELECTASIS; DEOXYRIBONUCLEASE I; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT, NEWBORN; INTUBATION, INTRATRACHEAL; MALE; NEBULIZERS AND VAPORIZERS; TREATMENT OUTCOME;

EID: 34247480978     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Nasr SZ, Strouse PJ, Soskolne E, Maxvold NJ, Garver KA, Rubin BK, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest. 2001;120:203-8.
2. Merkus PJ, de Hoog M, van Gent R, de Jongste JC. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Eur Respir J. 2001;18:734-7.
3. Fitzgerald DA, Hilton J, Jepson B, Smith L. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Pediatrics. 2005;116:e549-54.
4. El Hassan NO, Chess PR, Huysman MW, Merkus P, de Jongste JC. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics. 2001;108:468-70.
5. Kupeli S, Teksam O, Dogru D, Yurdakok M. Use of recombinant human DNase in a premature infant with recurrent atelectasis. Pediatr Int. 2003;45:584-6.
6. Kamin W, Klar-Hlawatsch B, Truebel H. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme). Klin Padiatr. 2006;218:88-91.
7. Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJ. DNase and atelectasis in non-cystic fibrosis pediatric patients. Crit Care. 2005;9:R351-6.
8. Riethmueller J, Borth-Bruhns T, Kumpf M, Vonthein R, Wiskirchen J, Stern M, et al. Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children. Pediatr Pulmonol. 2006;41:61-6.
9. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998;113:1329-34.
10. Bryson HM, Sorkin EM. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs. 1994;48:894-906.
11. Wills PJ, Wodehouse T, Corkery K, Mallon K, Wilson R, Cole PJ. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum